China Jo-Jo Drugstores In... (CJJD)
NASDAQ: CJJD
· Real-Time Price · USD
1.52
-0.09 (-5.59%)
At close: Mar 03, 2025, 3:58 PM
China Jo-Jo Drugstores Revenue Breakdown
Period Ending | Mar 31, 2022 | Mar 31, 2021 |
---|---|---|
DrugWholesaleMember Revenue | 164.51K | 34.55M |
DrugWholesaleMember Revenue Growth | -99.52% | n/a |
OnlinePharmacyMember Revenue | 3.81M | 22.49M |
OnlinePharmacyMember Revenue Growth | -83.04% | n/a |
RetailDrugstoresMember Revenue | 3.5M | 76.1M |
RetailDrugstoresMember Revenue Growth | -95.40% | n/a |
WholesaleMember Revenue | 164.51K | n/a |
WholesaleMember Revenue Growth | n/a | n/a |
Operating Expense Breakdown
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 8.41M | 8.41M | 9.48M | 9.48M | 7.84M | 7.84M | 18.52M | 18.52M | 9.08M | 9.08M | 23.17M | 11.59M | 15.89M | 7.95M | 6.47M | 14.45M | 8.54M | 8.39M | 8.04M | 6.73M | 8.31M | 8.82M | 3.1M | 9.26M | 7.44M | 6.18M | 15.96M | 7.76M | 7.21M | 5.64M | 6.58M | 5.02M | 4.41M | 4.6M | 4.11M | 5.16M | 4.26M | 4.02M | 2.39M |
Selling, General, and Administrative Revenue Growth | 0.00% | -11.31% | 0.00% | +20.98% | 0.00% | -57.68% | 0.00% | +103.91% | 0.00% | -60.80% | +100.00% | -27.09% | +100.00% | +22.84% | -55.25% | +69.32% | +1.72% | +4.36% | +19.48% | -19.01% | -5.79% | +184.32% | -66.50% | +24.50% | +20.34% | -61.26% | +105.65% | +7.67% | +27.72% | -14.24% | +31.00% | +13.98% | -4.24% | +12.06% | -20.35% | +21.05% | +6.02% | +67.79% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue | 7.05M | 7.05M | 2.93M | 2.93M | 7.02M | 7.02M | 7.32M | 7.32M | 7.27M | 7.27M | 8.79M | 8.79M | 6.65M | 6.65M | 5.94M | 8.26M | 6.48M | 6.27M | 5.66M | 5.68M | 6.49M | 5.97M | 7.73M | 6.69M | 5.22M | 4.63M | 5.45M | 5.02M | 4.35M | 3.92M | 3.65M | 3.57M | 3.02M | 2.68M | 2.56M | 3.29M | 3.42M | 3.1M | 4.53M |
Sales and Marketing Revenue Growth | 0.00% | +140.95% | 0.00% | -58.32% | 0.00% | -4.11% | 0.00% | +0.80% | 0.00% | -17.37% | 0.00% | +32.28% | 0.00% | +11.81% | -28.06% | +27.60% | +3.24% | +10.77% | -0.24% | -12.48% | +8.67% | -22.75% | +15.51% | +28.05% | +12.89% | -15.12% | +8.56% | +15.40% | +11.08% | +7.40% | +2.15% | +18.09% | +12.70% | +4.83% | -22.14% | -3.86% | +10.41% | -31.65% | n/a |